WHAT'S NEW

"Anti-VEGF Agent Aflibercept is Approved in Japan for Treatment of Diabetic Macular Edema: http://t.co/o5BBq6a47i - 13 hours ago via Twitter
"Good news! The benefits of anti-VEGF therapy are becoming more accessible-- anti-VEGF agent Aflibercept gets approved in Japan for treatment of Diabetic Macular Edema: - 18 hours ago via Facebook
"Diabetic macular edema (DME), a complication of diabetes, is a common cause of vision loss in people with diabetes. Anti-VEGF therapy has shifted the paradigm for treating DME and offers DME patients new hope to protect their vision. In honor of national Diabetes month, share the info and help save vision. - 2 days ago via Facebook
"Have you seen U2’s Hearts+Minds campaign? Check out the causes U2 has supported. We're honored to be in the mix! u2.com/heartsandminds - 5 days ago via Facebook
"Angiogenesis is your lifeline. Find out why: http://t.co/nBxBHgkcrC - 5 days ago via Twitter
"Angiogenesis Pioneer Dr. Judah Folkman’s Legacy of Bold and Creative Thinking Endures: http://t.co/PAPBF8rsHi - 6 days ago via Twitter
"Good news! Bevacizumab, an antiangiogenic agent, has been FDA approved for treating platinum-resistant recurrent ovarian cancer, giving patients more options and new hope. - 7 days ago via Facebook
"It's been a busy year! Check out our latest white papers, patient guides and infographics-- all available here: http://t.co/6OVb4A9jtp - 7 days ago via Twitter
"Join us in acknowledging World Diabetes Day by sharing helpful resources to stop the diabetes epidemic. A common complication of diabetes, Diabetic Macular Edema, is a leading cause of vision loss in working adults. Help save vision by sharing the Science of DME: www.scienceofdme.org - 1 week ago via Facebook
"Good News: Antiangiogenic agent bevacizumab is FDA approved for treating platinum-resistant recurrent ovarian cancer: http://t.co/7w5vjunUjL - 1 week ago via Twitter
The U.S. Food and Drug Administration (FDA) approved antiangiogenic agent bevacizumab (Avastin®) in combination with chemotherapy for the treatment o Read More >
"How can we predict response to therapy in metastatic CRC? Could AngioPredict lead the way? See the lecture here: http://t.co/YWZ8KmSEKi - 1 week ago via Twitter
"In the healthy body, a series of biologic "on" and "off” switches help modulate angiogenesis. Learn more here: - 1 week ago via Facebook
"Restoring the body’s natural control of angiogenesis, new blood vessel growth, is a new approach to fighting disease: - 1 week ago via Facebook
"Did you know? The dense network of blood vessels in a human body that carry blood to and from the heart is over 60,000 miles long. - 1 week ago via Twitter
"We’ve received the highest “4-star” rating from @CharityNav for best nonprofit practices. RT to celebrate with us! http://t.co/5vF0Z2Sgxf - 2 weeks ago via Twitter
"We did it again! For the second consecutive year, the Foundation is awarded with the highest “4-star” rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability, and transparency: http://reut.rs/149Vw04 This milestone reflects our commitment to best nonprofit practices and affirms that we are worthy of your support. Please make a donation today to save a life: www.donateangio.org - 2 weeks ago via Facebook
"Many foods have natural antiangiogenic properties. Learn more about eating to beat cancer & join the movement: http://t.co/xYcKCRxl2S - 2 weeks ago via Twitter
"Angiogenesis treatment can benefit patients with many life-threatening diseases- view our publications to learn more: - 2 weeks ago via Facebook
"FDA Approves Ramucirumab Plus Paclitaxel for Advanced Gastric Cancer: - 2 weeks ago via Facebook
"Angiogenesis-dependent diseases result when new blood vessels either grow excessively or insufficiently. Learn more: http://t.co/vAMlYHkJrp - 2 weeks ago via Twitter
"Angiogenesis-dependent diseases result when new blood vessels either grow excessively or insufficiently. Learn more: - 2 weeks ago via Facebook
On October 14, the Angiogenesis Foundation hosted a Patient Forum and Dinner, "Antiangiogenesis: Answer to Cancer," at the Westin Boston Waterfront Ho Read More >
The U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Retinal Vein Occ Read More >
Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Read More >
The U.S. Food and Drug Administration, on August 14, 2014 approved bevacizumab solution for intravenous infusion (Avastin®, Genentech, Inc.) for the Read More >
Aflibercept (EYLEA) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema (DME). Read More >
The U.S. Food and Drug Administration (FDA) has approved aflibercept (EYLEA®) Injection for the treatment of Diabetic Macular Edema (DME). The recom Read More >
The U.S. Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) from Genentech and granted Priority Revie Read More >
In a new study published online in the Journal of the American Heart Association June 12, 2014, researchers at Columbia Engineering report that they h Read More >
A new oral drug called lenvatinib looks promising as a treatment for a type of thyroid cancer that resists standard radiation, according to a later-st Read More >
Bevacizumab (Avastin) becomes the first biologic medicine to be recommended for treating platinum-resistant recurrent ovarian cancer, the most challen Read More >

ANGIO LIFE

Dr. Li shares 22 Cancer Fighting Tips with Dr. Oz

Dr. William Li joins Dr. Oz to share 22 ways to cut your risk of cancer risk by 50 percent. Read More >

Dr. William Li presents at TED

Dr. William Li presents “Can we eat to starve cancer?” at TED 2010 in Long Beach, CA. Read More >

 

IN THE MEDIA

4744.Reuters-Logo

November 6, 2014: For the second consecutive year, the Angiogenesis Foundation has received the highest rating from Charity Navigator, the prominent independent evaluator of charities. Read More >

DoctorOZ-1

May 20, 2014: “The Dr. Oz Show” features Dr. William Li who shares 3 all-natural breakthroughs that can reduce your risk of cancer. Read More >

marketwatch-logo

April 23, 2014: The Bates-Jensen Wound Reach Foundation and the Angiogenesis Foundation announce Keith Brantly will run in the Wound Reach Foundation OUCH! Race. Read More >

DoctorOZ (1)

February 7, 2014: Dr. William Li appears on “The Dr. Oz Show” to share 22 ways to cut your cancer risk by 50%. Read More >

yahoo-news-logo

January 21, 2014: The Angiogenesis Foundation, in collaboration with musician / activist Peter Gabriel, has launched the Do iT Yourself Health Revolution Read More >

yahoo-news-logo

November 7, 2013: The Angiogenesis Foundation receives highest rating from Charity Navigator, a premiere charity evaluator, for good governance, fiscal management, accountability and transparency. Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Launches Multimedia Campaigns for Saving Vision at the 13th Euretina Congress Read More >

bostoncomlogo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer at the European Cancer Congress 2013 Read More >

marketwatch-logo

September 26, 2013: The Angiogenesis Foundation Releases International White Paper on Advancing Treatment of Wet Age-Related Macular Degeneration at the 13th Euretina Congress Read More >

WSJ-Logo2

July 16, 2013: The Angiogenesis Foundation Presents Concept of Antiangiogenic Foods at IFT 2013 Annual Meeting + Food Expo Read More >

usatoday_logo

June 4, 2013: Dr. William Li discusses the impact of drug shortages for cancer patients in USA Today. Read More >

usatoday_logo

June 3, 2013: Dr. William Li discusses recent developments for patients with metastatic thyroid cancer in USA Today. Read More >

WSJ-Logo2

May 31, 2013: The Angiogenesis Foundation releases Advancing Critical Pathways Forward in the Treatment of Colorectal and Kidney Cancer – White Papers at the ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 30, 2013: The Angiogenesis Foundation Launches Science of Colorectal Cancer Patient Resource at ASCO Annual Meeting 2013. Read More >

WSJ-Logo2

May 7, 2013: The Angiogenesis Foundation releases white paper, “Critical Pathways Forward for Wet Age-Related Macular Degeneration in Asia Pacific.” Read More >

HEAR FROM THE EXPERTS

   

The “Best of Antiangiogenesis” is a series of webcasts, generated through Project ENABLE™, featuring presentations from leading medical experts describing research and perspectives on new angiogenesis-based therapies.

To view additional webcasts, click here
 

LEARN ABOUT DISEASE TREATMENTS

PUBLICATIONS

GREEN TEA

Our tea research is part of our Eat to Beat Cancer initiative, which is setting out to find foods and beverages that restore balance to the body's angiogenesis system. By purchasing this tea you are supporting our research and helping to advance the frontiers of cancer prevention.